| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.7M | +0.1% |
| R&D Expense | $28.5M | -50.4% |
| SG&A Expense | $13.8M | -25.3% |
| Operating Income | -$36.1M | +50.6% |
| Pre-tax Income | -$33.4M | +47.1% |
| Income Tax | $0 | — |
| Net Income | -$33.4M | +47.1% |
| EPS (Basic) | -$17.85 | -981.8% |
| EPS (Diluted) | -$17.85 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.7M | +62.4% |
| Short-term Investments | $15.8M | -60.6% |
| Current Assets | $30.3M | -40.4% |
| Total Assets | $56.7M | -43.0% |
| Current Liabilities | $8.4M | -46.8% |
| Total Liabilities | $30.2M | -28.7% |
| Stockholders' Equity | $26.5M | -53.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.9M | +35.0% |
| Capital Expenditures | $72K | +75.6% |
| Investing Cash Flow | $44.3M | -23.1% |
| Financing Cash Flow | $19K | -82.4% |
| Free Cash Flow | -$39.9M | +34.9% |
| -981.8% |